Aspart insulin
Aspart insulin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients
Carbohydrate Consumption as a Factor in Aspart Dosing
Cardiac Surgery Neuroprotection Study in Elders
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care
Clinical Trials (5)
Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients
Carbohydrate Consumption as a Factor in Aspart Dosing
Cardiac Surgery Neuroprotection Study in Elders
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5